Name | 3-(4-methoxyphenyl)-5-(((4-(4-methoxyphenyl)-5-methyl-4H-1,2,4-triazol-3-yl)thio)methyl)-1,2,4-oxadiazole |
---|
Description | TC-E 5001 is an inhibitor of Wnt pathway that inhibits tankyrase 1/2 (TNKS1/2) via novel adenosine pocket binding, with Kds of 79 nM and 28 nM, respectively. TC-E 5001 also inhibits Axin2 and STF, with IC50s of 0.709 μM and 0.215 μM, respectively[1][2]. |
---|---|
Related Catalog | |
Target |
TNKS1:79 nM (Ki) TNKS2:28 nM (Ki) |
In Vitro | TC-E 5001 inhibits TNKS2, with an IC50 of 33 nM[1]. |
References |
Molecular Formula | C20H19N5O3S |
---|---|
Molecular Weight | 409.46 |
Exact Mass | 409.12100 |
PSA | 113.39000 |
LogP | 3.93520 |
Hazard Codes | Xi |
---|